University HealthCare Alliance

January 30, 2020

Stanford Interstitial Lung Disease Symposium: Diagnosing and Treating Fibrosing Interstitial Lung Diseases

This CME event, led by the Stanford Division of Pulmonary, Allergy and Critical Care Medicine, seeks to fulfill the needs of practicing pulmonologists, primary care physicians, advanced-practice providers, and allied health care practitioners in the academic and community settings to achieve an accurate diagnosis and implement a comprehensive treatment plan for patients with interstitial lung disease.

A team of multidisciplinary experts will address common challenges with an emphasis on the role of accurate radiographic interpretation, in combination with diagnostic testing and classification, and disease management strategies. The goal of the symposium is to improve the delivery of early, appropriate, and comprehensive care to the patient with the interstitial lung disease.

Date & Location
Saturday, February 29, 2020, 7:00am – 5:00pm, Li Ka Shing Center for Learning and Knowledge (LKSC), Stanford, CA

Target Audience
Critical Care & Pulmonology, Internal Medicine

At the conclusion of this activity, participants should be able to: 
  1. Demonstrate the application of radiologic algorithms and classification criteria to IPF and non-IPF ILDs.
  2. Summarize the key points of ILD classification as stated in the current ATS ILD Guidelines.
  3. Review the criteria for initiating therapy in fibrotic and non-fibrotic ILDs and analyze the long-term monitoring process.
  4. Describe the criteria to determine appropriate timing for the referral of an ILD patient for a lung transplant evaluation.

The Stanford University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Read More